1083 related articles for article (PubMed ID: 15313942)
21. Choices: a study of preferences for end-of-life treatments in patients with advanced heart failure.
MacIver J; Rao V; Delgado DH; Desai N; Ivanov J; Abbey S; Ross HJ
J Heart Lung Transplant; 2008 Sep; 27(9):1002-7. PubMed ID: 18765193
[TBL] [Abstract][Full Text] [Related]
22. Cost-effectiveness analysis of continuous-flow left ventricular assist devices as destination therapy.
Rogers JG; Bostic RR; Tong KB; Adamson R; Russo M; Slaughter MS
Circ Heart Fail; 2012 Jan; 5(1):10-6. PubMed ID: 22052901
[TBL] [Abstract][Full Text] [Related]
23. The influence of infection on survival and successful transplantation in patients with left ventricular assist devices.
Argenziano M; Catanese KA; Moazami N; Gardocki MT; Weinberg AD; Clavenna MW; Rose EA; Scully BE; Levin HR; Oz MC
J Heart Lung Transplant; 1997 Aug; 16(8):822-31. PubMed ID: 9286774
[TBL] [Abstract][Full Text] [Related]
24. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.
John R; Kamdar F; Liao K; Colvin-Adams M; Boyle A; Joyce L
Ann Thorac Surg; 2008 Oct; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167
[TBL] [Abstract][Full Text] [Related]
25. A dose-dependent increase in mortality with vesnarinone among patients with severe heart failure. Vesnarinone Trial Investigators.
Cohn JN; Goldstein SO; Greenberg BH; Lorell BH; Bourge RC; Jaski BE; Gottlieb SO; McGrew F; DeMets DL; White BG
N Engl J Med; 1998 Dec; 339(25):1810-6. PubMed ID: 9854116
[TBL] [Abstract][Full Text] [Related]
26. Right heart failure after left ventricular assist device implantation in patients with chronic congestive heart failure.
Dang NC; Topkara VK; Mercando M; Kay J; Kruger KH; Aboodi MS; Oz MC; Naka Y
J Heart Lung Transplant; 2006 Jan; 25(1):1-6. PubMed ID: 16399523
[TBL] [Abstract][Full Text] [Related]
27. Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device.
Pagani FD; Miller LW; Russell SD; Aaronson KD; John R; Boyle AJ; Conte JV; Bogaev RC; MacGillivray TE; Naka Y; Mancini D; Massey HT; Chen L; Klodell CT; Aranda JM; Moazami N; Ewald GA; Farrar DJ; Frazier OH;
J Am Coll Cardiol; 2009 Jul; 54(4):312-21. PubMed ID: 19608028
[TBL] [Abstract][Full Text] [Related]
28. Outcomes after implantation of partial-support left ventricular assist devices in inotropic-dependent patients: Do we still need full-support assist devices?
Sabashnikov A; Popov AF; Bowles CT; Mohite PN; Weymann A; Hards R; Hedger M; Wittwer T; Wippermann J; Wahlers T; Schoendube FA; Simon AR
J Thorac Cardiovasc Surg; 2014 Sep; 148(3):1115-21; discussion 1021-2. PubMed ID: 25129605
[TBL] [Abstract][Full Text] [Related]
29. Long-term use of a left ventricular assist device for end-stage heart failure.
Rose EA; Gelijns AC; Moskowitz AJ; Heitjan DF; Stevenson LW; Dembitsky W; Long JW; Ascheim DD; Tierney AR; Levitan RG; Watson JT; Meier P; Ronan NS; Shapiro PA; Lazar RM; Miller LW; Gupta L; Frazier OH; Desvigne-Nickens P; Oz MC; Poirier VL;
N Engl J Med; 2001 Nov; 345(20):1435-43. PubMed ID: 11794191
[TBL] [Abstract][Full Text] [Related]
30. Left ventricular device as destination therapy: are we there yet?
Badiwala MV; Rao V
Curr Opin Cardiol; 2009 Mar; 24(2):184-9. PubMed ID: 19532106
[TBL] [Abstract][Full Text] [Related]
31. Effects of standard heart failure therapy and concomitant treatment with intravenous furosemide or inotropes (dobutamine, dopamine, and/or milrinone) on renal function and mortality in patients treated with nesiritide.
Kurien S; Warfield KT; Wood CM; Miller WL
Am J Cardiol; 2006 Dec; 98(12):1627-30. PubMed ID: 17145223
[TBL] [Abstract][Full Text] [Related]
32. Right heart failure and "failure to thrive" after left ventricular assist device: clinical predictors and outcomes.
Baumwol J; Macdonald PS; Keogh AM; Kotlyar E; Spratt P; Jansz P; Hayward CS
J Heart Lung Transplant; 2011 Aug; 30(8):888-95. PubMed ID: 21530314
[TBL] [Abstract][Full Text] [Related]
33. Physician-directed patient self-management of left atrial pressure in advanced chronic heart failure.
Ritzema J; Troughton R; Melton I; Crozier I; Doughty R; Krum H; Walton A; Adamson P; Kar S; Shah PK; Richards M; Eigler NL; Whiting JS; Haas GJ; Heywood JT; Frampton CM; Abraham WT;
Circulation; 2010 Mar; 121(9):1086-95. PubMed ID: 20176990
[TBL] [Abstract][Full Text] [Related]
34. Effects of continuous aortic flow augmentation in patients with exacerbation of heart failure inadequately responsive to medical therapy: results of the Multicenter Trial of the Orqis Medical Cancion System for the Enhanced Treatment of Heart Failure Unresponsive to Medical Therapy (MOMENTUM).
Greenberg B; Czerska B; Delgado RM; Bourge R; Zile MR; Silver M; Klapholz M; Haeusslein E; Mehra MR; Mather P; Abraham WT; Neaton JD; Brown BS; Parker IC; Konstam MA;
Circulation; 2008 Sep; 118(12):1241-9. PubMed ID: 18765394
[TBL] [Abstract][Full Text] [Related]
35. The use of continuous milrinone therapy as bridge to transplant is safe in patients with short waiting times.
Assad-Kottner C; Chen D; Jahanyar J; Cordova F; Summers N; Loebe M; Merla R; Youker K; Torre-Amione G
J Card Fail; 2008 Dec; 14(10):839-43. PubMed ID: 19041047
[TBL] [Abstract][Full Text] [Related]
36. Impact of left ventricular assist device bridging on posttransplant outcomes.
Pal JD; Piacentino V; Cuevas AD; Depp T; Daneshmand MA; Hernandez AF; Felker GM; Lodge AJ; Rogers JG; Milano CA
Ann Thorac Surg; 2009 Nov; 88(5):1457-61; discussion 1461. PubMed ID: 19853092
[TBL] [Abstract][Full Text] [Related]
37. The Seattle Heart Failure Model: prediction of survival in heart failure.
Levy WC; Mozaffarian D; Linker DT; Sutradhar SC; Anker SD; Cropp AB; Anand I; Maggioni A; Burton P; Sullivan MD; Pitt B; Poole-Wilson PA; Mann DL; Packer M
Circulation; 2006 Mar; 113(11):1424-33. PubMed ID: 16534009
[TBL] [Abstract][Full Text] [Related]
38. Changing outcomes in patients bridged to heart transplantation with continuous- versus pulsatile-flow ventricular assist devices: an analysis of the registry of the International Society for Heart and Lung Transplantation.
Nativi JN; Drakos SG; Kucheryavaya AY; Edwards LB; Selzman CH; Taylor DO; Hertz MI; Kfoury AG; Stehlik J
J Heart Lung Transplant; 2011 Aug; 30(8):854-61. PubMed ID: 21571550
[TBL] [Abstract][Full Text] [Related]
39. Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management in Ambulatory Heart Failure Patients: Results From the ROADMAP Study.
Estep JD; Starling RC; Horstmanshof DA; Milano CA; Selzman CH; Shah KB; Loebe M; Moazami N; Long JW; Stehlik J; Kasirajan V; Haas DC; O'Connell JB; Boyle AJ; Farrar DJ; Rogers JG;
J Am Coll Cardiol; 2015 Oct; 66(16):1747-1761. PubMed ID: 26483097
[TBL] [Abstract][Full Text] [Related]
40. Clinical outcomes are similar in pulsatile and nonpulsatile left ventricular assist device recipients.
Feller ED; Sorensen EN; Haddad M; Pierson RN; Johnson FL; Brown JM; Griffith BP
Ann Thorac Surg; 2007 Mar; 83(3):1082-8. PubMed ID: 17307463
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
